North Thames GLH Collaboration Shortlisted for HSJ ‘Provider collaboration of the Year’ Award

The North Thames Genomic Laboratory Hub (GLH) are proud to announce that a collaboration facilitated by the North Thames GLH has been shortlisted for ‘Provider Collaboration of the Year’ in the HSJ Awards 2022.

The collaboration between Royal Marsden Hospital NHS Foundation Trust (Royal Marsden) and Great Ormond Street Hospital for Children NHS Foundation Trust (GOSH) was established to transform standard of care diagnostics for paediatric haemato-oncology. Through an innovative testing panel and a streamlined service pathway maximising both partners’ expertise, this collaboration is improving diagnostic timelines and impacting clinical management decisions for children with blood cancer.

The teams at both organisations brought together scientific, clinical and research expertise supported by the North Thames GLH, and have worked incredibly hard to bring this service to patients.

Professor Michael Hubank, Head of Clinical Genomics (Research) at Royal Marsden and Scientific Director of North Thames GLH comments, “Paediatric haemato-oncology remains a leading cause of paediatric cancer mortality and through this collaboration we are enabling clinicians to better characterise cancers and personalise treatment. The HSJ Awards programme is allowing us to share our success and learnings, and we hope will help us ensure state-of-the-art techniques are available to the largest number of patients possible.”

“We are really proud of how this work is impacting the diagnosis and treatment of infants and children with blood cancers. Being able to offer rapid advanced genomic testing to all our patients increases our understanding of these cancers and will improve outcomes. It is great to see the hard work of the team being acknowledged through this award shortlisting” added Dr Jack Bartram, Consultant paediatric haematologist, GOSH.

The ’Provider Collaboration of the Year’ award recognises work conducted to align priorities between provider organisations, which lead to greater efficiency and the development of person-centred services. This could be formally, as part of a regional or national clinical network or development of a wider hospital chain, or more informally through shared resources: the real importance is that patients derive benefit from the arrangement.
The full list of nominees for the 2022 HSJ awards can be found at

Events Healthcare Professionals

New Course: Genomics Essentials for Paediatric Oncology

An overview of hereditary cancer predisposition in children

This one day learning event organised by the North East Thames Cancer
Genetics team will give an overview of paediatric cancer genetic syndromes and covers aspects of diagnosis, management and genetic counselling.

The faculty consists of clinicians from GOSH and beyond who are national and international experts in their field.

The course is for any healthcare professional interested in broadening their
understanding of hereditary cancer predisposition in children. It is particularly suitable for:

Clinical Genetics Registrars, Consultant Clinical Geneticists, Oncology Registrars, Consultant Oncologists and Paediatric Oncology Nurses

Learning Outcomes

  • Improved understanding of hereditary conditions which predispose to cancer in childhood
  • Improved understanding of surveillance options for managing cancer risk in childhood
  • Exploring the genetic counselling challenges in a paediatric cancer genetics setting

Date: Tuesday 11th October 2022 9.10 16.30
Venue: Online (Zoom)
CPD Accreditation: In progress
Cost: £125

For more information contact